Vireo Growth (VREOF) Total Debt (2020 - 2026)
Vireo Growth (VREOF) posted Total Debt of $198.6 million for Q1 2026, up 38.01% sequentially from $143.9 million in Q4 2025, and up 217.23% YoY from $62.6 million in Q1 2025.
Vireo Growth (VREOF) Total Debt (2020 - 2026) Analysis & Trends
Vireo Growth has reported Total Debt for 7 years, with the latest figure at $198.6 million in Q1 2026.
- Quarterly Total Debt rose 217.23% year-over-year to $198.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.6 million (up 217.23% YoY) and the FY2025 annual result came in at $143.9 million, up 127.69% from the prior year.
- Total Debt rose to $198.6 million in Q1 2026 per VREOF's latest filing, from $143.9 million in the prior quarter.
- Over five years, Total Debt peaked at $198.6 million in Q1 2026 and troughed at $31.2 million in Q1 2022.
- A 5-year average of $81.9 million and a median of $60.9 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2026: Total Debt plunged 47.53% in 2024, then jumped 217.23% in 2026.
- Over 5 years, Total Debt stood at $58.0 million in 2022, then surged by 107.55% to $120.4 million in 2023, then tumbled by 47.53% to $63.2 million in 2024, then surged by 127.69% to $143.9 million in 2025, then jumped by 38.01% to $198.6 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $198.6 million, $143.9 million, and $147.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 760.00 Mn |
| 10 | Vireo Growth | 487.39 Mn | 345.09 Mn | 95.30 Mn | 298.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198.60 Mn |
| Dec 31, 2025 | 143.90 Mn |
| Sep 30, 2025 | 147.30 Mn |
| Jun 30, 2025 | 108.70 Mn |
| Mar 31, 2025 | 62.60 Mn |
| Dec 31, 2024 | 63.20 Mn |
| Sep 30, 2024 | 57.98 Mn |
| Jun 30, 2024 | 62.62 Mn |
| Mar 31, 2024 | 60.90 Mn |
| Dec 31, 2023 | 120.44 Mn |
| Sep 30, 2023 | 59.49 Mn |
| Jun 30, 2023 | 57.77 Mn |
| Mar 31, 2023 | 58.21 Mn |
| Dec 31, 2022 | 58.03 Mn |
| Sep 30, 2022 | 55.63 Mn |
| Jun 30, 2022 | 45.85 Mn |
| Mar 31, 2022 | 31.21 Mn |
| Dec 31, 2021 | 27.33 Mn |
| Sep 30, 2021 | 21.63 Mn |
| Jun 30, 2021 | 19.64 Mn |